WELL Health Technologies Corp.
WHTCF
$3.11
-$0.16-4.83%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 35.58% | 49.67% | 49.49% | 32.91% | 22.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.58% | 49.67% | 49.49% | 32.91% | 22.59% |
| Cost of Revenue | 25.20% | 34.81% | 37.82% | 32.06% | 27.89% |
| Gross Profit | 50.81% | 72.90% | 67.36% | 34.10% | 15.57% |
| SG&A Expenses | 33.19% | 38.12% | 31.12% | 26.38% | 19.64% |
| Depreciation & Amortization | 22.36% | 33.19% | 27.52% | 32.25% | 22.55% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.60% | 35.78% | 34.78% | 30.17% | 24.67% |
| Operating Income | 1,514.00% | 557.16% | 426.99% | 256.43% | -70.00% |
| Income Before Tax | 115.43% | 194.39% | -26.40% | -139.01% | -185.24% |
| Income Tax Expenses | 138.85% | 104.08% | 105.12% | 158.11% | 20.45% |
| Earnings from Continuing Operations | 114.11% | 262.23% | -80.55% | -142.52% | -176.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -830.52% | -964.51% | -452.26% | 157.86% | 90.63% |
| Net Income | 103.41% | 213.69% | -117.88% | -138.89% | -185.10% |
| EBIT | 1,514.00% | 557.16% | 426.99% | 256.43% | -70.00% |
| EBITDA | 143.82% | 417.46% | 522.17% | 65.62% | -5.34% |
| EPS Basic | 103.32% | 223.41% | -118.50% | -135.61% | -183.14% |
| Normalized Basic EPS | 94.92% | 117.08% | 116.70% | 81.62% | 2.21% |
| EPS Diluted | 102.74% | 200.14% | -124.27% | -140.26% | -185.95% |
| Normalized Diluted EPS | 94.25% | 116.60% | 116.37% | 80.47% | -0.34% |
| Average Basic Shares Outstanding | 4.47% | 4.98% | 5.33% | 0.27% | 0.88% |
| Average Diluted Shares Outstanding | 4.37% | 4.82% | 4.08% | -0.86% | -0.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |